Quality assessment | No. of patients | Treatment effect (95% CI) | Quality of the evidence | |||||||
---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Design | Limitations | Inconsistency | Indirectness | Imprecision | Other considerations | OMT | All other interventions and sham treatment | ||
Pain (follow-up 3 months; measured with: Pain VAS from 0 to 100 [worse pain]; Better indicated by lower values) | ||||||||||
10 | randomised trials | no serious limitations | serious1 | no serious indirectness | no serious imprecision | none | 566 | 575 | MD 12.91 lower (20 to 5.82 lower) | ⊕ ⊕ ⊕Ο MODERATE |
Functional status (follow-up 3 months; measured with: Roland-Morris Disability Questionnaire, Oswestry Disability Index; Better indicated by lower values) | ||||||||||
9 | randomised trials | no serious limitations | serious1 | no serious indirectness | no serious imprecision | none | 529 | 517 | SMD 0.36 lower (0.58 to 0.14 lower) | ⊕ ⊕ ⊕Ο MODERATE |